| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.095 | 0.003 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.003 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.004 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.096 | 0.004 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.004 |